Parents of Children with Sickle Cell Disease Are Interested in Preimplantation Genetic Testing - 22/07/20

Abstract |
Objective |
To evaluate awareness of and attitudes toward preimplantation genetic testing (PGT) for sickle cell disease (SCD) among parents of children with SCD.
Study design |
Parents of children with SCD were given an educational handbook on PGT before a routine SCD clinic visit. After their clinic visit, parents were asked to complete an anonymous survey.
Results |
Of 83 patents approached, 67 (81%) completed the survey. Only 16 of the 67 parents (24%) were previously aware of PGT for SCD. After our clinic-based education, 65 of the 67 parents (97%) indicated that it was important or very important for parents of children with SCD to know about PGT. Among parents interested in having more children, 29 of 32 (91%) would personally consider using PGT if covered by insurance.
Conclusions |
Parents of children with SCD are generally not aware of PGT. When educated in clinic, parents viewed information on PGT as valuable. Pediatricians and other health care professionals should inform parents of children with SCD about this reproductive option.
Le texte complet de cet article est disponible en PDF.Keywords : genetic counseling, assisted reproductive technology, reproductive choices, sickle cell anemia, preimplantation genetic diagnosis
Abbreviations : HSCT, IVF, PGT, SCD
Plan
The authors declare no conflicts of interest. |
Vol 223
P. 178 - août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?